Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland

OBJECTIVE: We aimed to identify the most cost-effective of all prophylactic measures available in Switzerland for women not yet affected by breast and ovarian cancer who tested positive for a BRCA1/2 mutation. METHODS: Prophylactic bilateral mastectomy (PBM), salpingo-oophorectomy (PBSO), combined P...

Descripción completa

Detalles Bibliográficos
Autores principales: Bommer, Claudine, Lupatsch, Judith, Bürki, Nicole, Schwenkglenks, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170622/
https://www.ncbi.nlm.nih.gov/pubmed/34767113
http://dx.doi.org/10.1007/s10198-021-01396-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170622/
https://www.ncbi.nlm.nih.gov/pubmed/34767113
http://dx.doi.org/10.1007/s10198-021-01396-9

Ejemplares similares